Item 5.07. Submission of Matters to a Vote of Security Holders.

The 2023 Annual Meeting of Shareholders (the "Annual Meeting") of Tenet Healthcare Corporation (the "Company") was held on May 25, 2023. Below are the final voting results from the meeting.

1. The Company's shareholders elected the following directors to serve on the Company's Board of Directors, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected or qualified, whichever is later, or until the director's earlier resignation or removal:


                                                                                     BROKER
                                FOR              AGAINST           ABSTAIN          NON-VOTES
J. Robert Kerrey            83,535,834        2,527,226          514,682          6,815,599
James L. Bierman            85,146,732          922,183          508,827          6,815,599
Richard W. Fisher           85,044,275        1,026,111          507,356          6,815,599
Meghan M. FitzGerald        84,827,178        1,243,901          506,663          6,815,599
Cecil D. Haney              85,137,286          933,335          507,121          6,815,599
Christopher S. Lynch        85,082,827          986,640          508,275          6,815,599
Richard J. Mark             85,083,075          987,427          507,240          6,815,599
Tammy Romo                  84,908,989        1,161,247          507,506          6,815,599
Saumya Sutaria              85,664,645          401,556          511,541          6,815,599
Nadja Y. West               85,139,884          929,376          508,482          6,815,599



2.  The Company's shareholders approved, on an advisory basis, the Company's
executive compensation:

                                                  BROKER
     FOR            AGAINST        ABSTAIN       NON-VOTES
  81,530,105       4,617,910       429,727       6,815,599

3. Votes regarding the approval, on an advisory basis, of the frequency of future advisory votes on the Company's executive compensation were as follows:



                                                                    BROKER
  ONE YEAR       TWO YEARS       THREE YEARS         ABSTAIN       NON-VOTES
 84,450,639       40,680        2,057,781            28,642        6,815,599

Based on the voting result at the Annual Meeting, the Company's Board of Directors has determined to provide for a shareholder advisory vote on executive compensation on an annual basis.

4. The Company's shareholders approved the ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accountants for the year ending December 31, 2023:



                                                  BROKER
     FOR            AGAINST        ABSTAIN       NON-VOTES
  92,610,717        742,949        39,675            -

5. The shareholder proposal requesting a report on patients' right to access abortion in emergencies did not pass



                                                BROKER
    FOR          AGAINST         ABSTAIN       NON-VOTES
 7,449,831      77,442,867      1,685,044      6,815,599

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses